1. Home
  2. ITOS vs UNTY Comparison

ITOS vs UNTY Comparison

Compare ITOS & UNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • UNTY
  • Stock Information
  • Founded
  • ITOS 2011
  • UNTY 1991
  • Country
  • ITOS United States
  • UNTY United States
  • Employees
  • ITOS N/A
  • UNTY N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • UNTY Major Banks
  • Sector
  • ITOS Health Care
  • UNTY Finance
  • Exchange
  • ITOS Nasdaq
  • UNTY Nasdaq
  • Market Cap
  • ITOS 323.2M
  • UNTY 311.8M
  • IPO Year
  • ITOS 2020
  • UNTY 1997
  • Fundamental
  • Price
  • ITOS $9.17
  • UNTY $44.72
  • Analyst Decision
  • ITOS Strong Buy
  • UNTY Buy
  • Analyst Count
  • ITOS 4
  • UNTY 2
  • Target Price
  • ITOS $32.50
  • UNTY $41.50
  • AVG Volume (30 Days)
  • ITOS 692.7K
  • UNTY 37.0K
  • Earning Date
  • ITOS 11-15-2024
  • UNTY 10-11-2024
  • Dividend Yield
  • ITOS N/A
  • UNTY 1.16%
  • EPS Growth
  • ITOS N/A
  • UNTY 2.67
  • EPS
  • ITOS N/A
  • UNTY 3.90
  • Revenue
  • ITOS $35,000,000.00
  • UNTY $100,814,000.00
  • Revenue This Year
  • ITOS $271.18
  • UNTY N/A
  • Revenue Next Year
  • ITOS N/A
  • UNTY $11.86
  • P/E Ratio
  • ITOS N/A
  • UNTY $11.47
  • Revenue Growth
  • ITOS N/A
  • UNTY 0.70
  • 52 Week Low
  • ITOS $8.41
  • UNTY $24.74
  • 52 Week High
  • ITOS $18.75
  • UNTY $46.17
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 46.37
  • UNTY 73.21
  • Support Level
  • ITOS $8.41
  • UNTY $38.07
  • Resistance Level
  • ITOS $9.14
  • UNTY $40.41
  • Average True Range (ATR)
  • ITOS 0.49
  • UNTY 1.30
  • MACD
  • ITOS 0.21
  • UNTY 0.47
  • Stochastic Oscillator
  • ITOS 71.58
  • UNTY 82.86

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.

Share on Social Networks: